INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Corporate insider
MV

Meluzio Michael Vincent

VP, Prin. Accounting OfficerCIK 0002138368

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 4
Max Insider Score33
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
27
MV
Meluzio Michael VincentVP, Prin. Accounting Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$32K
1,144 sh
Oct 12, 2026Oct 14, 2026
traded Oct 12, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Cue Biopharma, Inc.VP, Prin. Accounting Officer · Aug 17, 2026
33
MV
Meluzio Michael VincentVP, Prin. Accounting Officer
CUECue Biopharma, Inc.
Open-market sale
SELL
$125K
4,106 sh
Aug 13, 2026
Aug 17, 2026
traded Aug 13, 2026
+4d
SEC FORM 4

Evidence

26
MV
Meluzio Michael VincentVP, Prin. Accounting Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$93.39
3 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC FORM 4

Evidence

21
MV
Meluzio Michael VincentVP, Prin. Accounting Officer
CUECue Biopharma, Inc.
Option exercise
M—
13.6K sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC FORM 4

Evidence

26
MV
Meluzio Michael VincentVP, Prin. Accounting Officer
CUECue Biopharma, Inc.
Open-market sale
SELL$45K
1,519 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC FORM 4

Evidence

17
MV
Meluzio Michael VincentVP, Prin. Accounting Officer
CUECue Biopharma, Inc.
Option exercise
M—
13.6K sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC FORM 4

Evidence